Trials / Completed
CompletedNCT02036255
Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase
Prevention of Tunneled Cuffed Catheter Malfunction With Prophylactic Use of a Taurolidine Locking Solution Containing Urokinase : a Multicentric Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The objective of our study is to investigate whether the substitution of the standard locking solution with a locking solution containing taurolidine and urokinase weekly (Taurolock ™ U 25,000 - www.taurolock.com ) reduces the rate of catheter dysfunction in hemodialysis patients with a history of TCC dysfunction requiring urokinase therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Taurolidine Urokinase | |
| DRUG | Taurolidine Heparin |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-07-01
- Completion
- 2018-05-01
- First posted
- 2014-01-14
- Last updated
- 2018-05-03
Locations
9 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02036255. Inclusion in this directory is not an endorsement.